CXCR inhibitor AMD3100, Purity ≥98%

Cat. No.: X23-10-ZQ571

CXCR inhibitor AMD3100, Purity ≥98%

Synonym: Plerixafor; 110078-46-1; Mozobil; AMD3100; 1,4-Bis((1,4,8,11-tetraazacyclotetradecan-1-yl)methyl)benzene; Amd 3100; CXCR inhibitor

  • MDL: MFCD05662218
  • CAS Number: 110078-46-1
  • Compound CID: 65015
Product Size
10 mg; 25 mg; 50 mg; 100 mg
Price
Datasheet
MSDS
Properties
Description
AMD3100, soluble in warmed water and ethanol and insoluble in DMSO, targets the chemokine receptors CXCR, which are part of the GPCR family. It targets CXCL12 mediated chemotaxis and CXCR4.
Molecular Weight
502.78
Molecular Formula
C28H54N8
Targets
CXCL12 mediated chemotaxis: 5.7 nM; CXCR4: 44 nM
Form
Lyophilized powder
Purity
≥98%
Solubility
DMSO: Insoluble; Warmed water: 3 mg/mL (5.96 mM); Ethanol: 86 mg/mL (171.05 mM)
Identity
Confirmed by NMR/HPLC/MS.
Stability
The product is stable for three years when stored at the recommended temperature in lyophilized powder.
Applications
AMD3100 can be used to investigate its effects as a CXCR4 antagonist in stem cell mobilization and HIV research.
Storage
Store at -20ºC.
Related Products

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.